Bristol Myers Squibb vs Johnson & Johnson
Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $122B
- Last close
- $59.56
- 12 months
- +26.6%
- Market value
- $656B
- Last close
- $272.70
- 12 months
- +36.4%
At a glance
- By market value, Johnson & Johnson ($656.5B) is about 5.4 times Bristol Myers Squibb ($121.7B).
- Over the last 12 months Bristol Myers Squibb's share price moved +26.6% and Johnson & Johnson's +36.4%; against the S&P 500 that is +15.9 points and +25.7 points.
- In their last fiscal years Bristol Myers Squibb kept 14.6% of revenue as net income and Johnson & Johnson 28.5%.
- In the last 90 days insiders reported 0 open-market purchases at Bristol Myers Squibb and 0 at Johnson & Johnson; members of Congress disclosed 0 trades in Bristol Myers Squibb and 4 in Johnson & Johnson.
- Next results: Bristol Myers Squibb Feb 3, 2027, Johnson & Johnson Jan 26, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Bristol Myers Squibb BMYNYSE · Pharmaceuticals | Johnson & Johnson JNJNYSE · Pharmaceuticals | |
|---|---|---|
| Size and profitability | ||
| Market value | $122B | $656B |
| Revenue, last fiscal year | $48.2B | $94.2B |
| Net income, last fiscal year | $7.05B | $26.8B |
| Net marginNet income as a share of revenue | 14.6% | 28.5% |
| Free cash flow | $12.8B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Bristol Myers Squibb against
Common questions
How do Bristol Myers Squibb and Johnson & Johnson compare in size?
Johnson & Johnson has the larger market value: Bristol Myers Squibb $122B and Johnson & Johnson $656B, at the last close.
Whose share price rose more over the last 12 months, BMY or JNJ?
Over the last 12 months Bristol Myers Squibb moved +26.6% and Johnson & Johnson +36.4%. Past price moves say nothing about the future.
Which has had more insider buying, Bristol Myers Squibb or Johnson & Johnson?
Since 2006, Bristol Myers Squibb insiders reported 47 open-market purchases against 25 for Johnson & Johnson. These are counts of what was filed, not a view on either stock.
Do members of Congress trade BMY or JNJ?
In the last 12 months, members of Congress disclosed 8 trades in Bristol Myers Squibb (BMY) and 26 in Johnson & Johnson (JNJ).
When did insiders last buy BMY and JNJ?
Bristol Myers Squibb: Apr 29, 2025. Johnson & Johnson: Dec 1, 2025.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Bristol Myers Squibb pageJohnson & Johnson pageRare insider trades this weekAll comparisons
https://oqro.io/compare/bmy-vs-jnj






